Validation Study of Novel Point-of-Care Tests for Infliximab, Adalimumab and C-Reactive Protein in Capillary Blood and Calprotectin in Faeces in an Ambulatory Inflammatory Bowel Disease Care Setting

Therapeutic Drug Monitoring of Biologics in Crohn’s Disease

(2022) Laurie B. Grossberg et al.   GASTROENTEROLOGY CLINICS OF NORTH AMERICA

Proactive Therapeutic Drug Monitoring Versus Conventional Management for Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis

(2022) Nghia H. Nguyen et al.   GASTROENTEROLOGY

STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD

(2021) Dan Turner et al.   GASTROENTEROLOGY

Point-of-Care Assays Could Be Useful for Therapeutic Drug Monitoring of IBD Patients in a Proactive Strategy with Adalimumab

(2020) Mohamad Cherry et al.   Journal of Clinical Medicine

Monitoring of Adalimumab Concentrations at Home in Patients with Inflammatory Bowel Disease using Dried Blood Samples

(2019) Sophie E. Berends et al.   THERAPEUTIC DRUG MONITORING

Infliximab trough levels: A comparison between the Quantum Blue Infliximab assay and the established ELISA

(2019) Ming Han Lim et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial

(2017) Jean-Frederic Colombel et al.   LANCET

Proactive therapeutic drug monitoring of infliximab: a comparative study of a new point-of-care quantitative test with two established ELISA assays

(2016) J. Afonso et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Comparison of Three Assays to Quantify Infliximab, Adalimumab, and Etanercept Serum Concentrations

(2016) Ji S. van Bezooijen et al.   THERAPEUTIC DRUG MONITORING

Rapid Test for Infliximab Drug Concentration Allows Immediate Dose Adaptation

(2016) Thomas Van Stappen et al.   Clinical and Translational Gastroenterology

Validation and evaluation of eight commercially available point of care CRP methods

(2015) Nannette Brouwer et al.   CLINICA CHIMICA ACTA

An Accelerated Infliximab Induction Regimen Reduces the Need for Early Colectomy in Patients With Acute Severe Ulcerative Colitis

(2015) David J. Gibson et al.   Clinical Gastroenterology and Hepatology

Biomarkers of Inflammation in Inflammatory Bowel Disease

(2015) Bruce E. Sands   GASTROENTEROLOGY

The association of tissue anti-TNF drug levels with serological and endoscopic disease activity in inflammatory bowel disease: the ATLAS study

(2015) Andres J Yarur et al.   GUT

Comparison of six different calprotectin assays for the assessment of inflammatory bowel disease

(2014) Delphine Labaere et al.   United European Gastroenterology Journal

A rapid assay for on-site monitoring of infliximab trough levels: a feasibility study

(2013) Paul L. A. M. Corstjens et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Detection of infliximab levels and anti-infliximab antibodies: a comparison of three different assays

(2012) N. Vande Casteele et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

(2012) Geert DʼHaens et al.   INFLAMMATORY BOWEL DISEASES